SETD1A regulates transcriptional pause release of heme biosynthesis genes in leukemia

Cell Rep. 2022 Nov 29;41(9):111727. doi: 10.1016/j.celrep.2022.111727.

Abstract

Histone methyltransferase SETD1A is critical for acute myeloid leukemia (AML) cell survival, but the molecular mechanism driving SETD1A gene regulation remains elusive. To delineate the role of SETD1A, we utilize a protein degrader technology to induce rapid SETD1A degradation in AML cell lines. SETD1A degradation results in immediate downregulation of transcripts associated with DNA repair and heme biosynthesis pathways. CRISPR-based functional analyses and metabolomics reveal an essential role of SETD1A to maintain mitochondrial respiration in AML cells. These SETD1A targets are enriched in head-to-head (H2H) genes. SETD1A degradation disrupts a non-enzymatic SETD1A domain-dependent cyclin K function, increases the Ser5P RNA polymerase II (RNAPII) at the transcriptional start site (TSS), and induces the promoter-proximal pausing of RNAPII in a strand-specific manner. This study reveals a non-enzymatic role for SETD1A in transcriptional pause release and provides insight into the mechanism of RNAPII pausing and its function in cancer.

Keywords: CP: Molecular biology; SETD1A; cyclin K; elongation; heme biosynthesis; leukemia.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • DNA Repair
  • Down-Regulation
  • Heme
  • Histone-Lysine N-Methyltransferase / genetics
  • Humans
  • Leukemia*
  • Metabolomics
  • RNA Polymerase II

Substances

  • RNA Polymerase II
  • Heme
  • Setd1A protein, human
  • Histone-Lysine N-Methyltransferase